Neural Computing in Medical Image Analysis for Cancer Detection

preprint OA: closed
Full text JSON View at publisher

Abstract

Abstract Early and accurate detection of cancerous tissues is critical for improving patient outcomes and optimizing treatment strategies. This study explores the application of convolutional neural networks (CNNs) in the analysis of medical images, such as MRI and CT scans, for cancer detection and classification. Leveraging advanced neural computing techniques, the proposed system aims to enhance diagnostic accuracy while minimizing false positives and false negatives. The research involves the development and validation of a CNN-based framework trained on a diverse dataset of annotated medical images. The model's performance is evaluated against conventional diagnostic methods and state-of-the-art deep learning approaches. Results indicate significant improvements in classification accuracy, robustness to variations in image quality, and computational efficiency. This study underscores the potential of neural computing to revolutionize cancer diagnostics and support clinicians in making informed decisions.
Full text 90,104 characters · extracted from preprint-html · click to expand
Neural Computing in Medical Image Analysis for Cancer Detection | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Neural Computing in Medical Image Analysis for Cancer Detection Khalid Ul Islam Rather This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-5764501/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Early and accurate detection of cancerous tissues is critical for improving patient outcomes and optimizing treatment strategies. This study explores the application of convolutional neural networks (CNNs) in the analysis of medical images, such as MRI and CT scans, for cancer detection and classification. Leveraging advanced neural computing techniques, the proposed system aims to enhance diagnostic accuracy while minimizing false positives and false negatives. The research involves the development and validation of a CNN-based framework trained on a diverse dataset of annotated medical images. The model's performance is evaluated against conventional diagnostic methods and state-of-the-art deep learning approaches. Results indicate significant improvements in classification accuracy, robustness to variations in image quality, and computational efficiency. This study underscores the potential of neural computing to revolutionize cancer diagnostics and support clinicians in making informed decisions. Convolutional Neural Networks Cancer Detection Medical Imaging Diagnostic Accuracy Figures Figure 1 Figure 2 Introduction Cancer remains one of the leading causes of mortality worldwide, contributing to millions of deaths annually. According to the World Health Organization (WHO), approximately 10 million people succumbed to cancer in 2020, accounting for nearly one in six deaths globally (WHO, 2021). Early detection is critical in improving treatment outcomes, as cancers identified at an early stage are often more responsive to therapy and associated with better prognoses. However, traditional diagnostic methods, such as the manual analysis of magnetic resonance imaging (MRI) and computed tomography (CT) scans, present significant challenges. These methods are time-intensive, require specialized expertise, and are prone to variability and human error (Esteva et al., 2017). In clinical practice, radiologists often face the burden of interpreting vast amounts of medical data, which can lead to delays in diagnosis and discrepancies in interpretation. In this context, artificial intelligence (AI) has emerged as a transformative force in medical diagnostics. Among AI techniques, neural computing-specifically convolutional neural networks (CNNs)-has shown remarkable success in image recognition tasks, including medical image analysis. CNNs excel in identifying complex patterns within images, making them particularly well-suited for the detection and classification of cancerous tissues. Unlike traditional rule-based algorithms, CNNs automatically learn hierarchical features from raw image data, eliminating the need for handcrafted features and enabling superior performance in complex tasks (LeCun, Bengio, & Hinton, 2015). This ability to automatically extract relevant features from images enables CNNs to process and analyze medical images with high efficiency and precision, overcoming many of the limitations associated with manual image interpretation. This study aims to leverage the power of CNNs to address the dual challenges of early and precise identification of cancerous tissues in medical imaging. By automating the diagnostic process, CNNs have the potential not only to enhance accuracy but also to significantly reduce the workload on radiologists and clinicians. With the capacity to analyze large datasets quickly and accurately, CNNs can provide faster diagnoses, which is crucial for timely interventions. This, in turn, can lead to improved patient outcomes and increased survival rates. Moreover, CNNs can help to reduce the incidence of false positives and false negatives, which are common challenges in traditional diagnostic methods. These improvements can ensure more reliable clinical decision-making and better patient management. Neural computing techniques, particularly CNNs, have already demonstrated their effectiveness in various domains of medical diagnostics. In dermatology, for instance, CNNs have been shown to achieve dermatologist-level accuracy in identifying skin cancer from images (Esteva et al., 2017). In other areas, such as lung cancer detection and breast cancer screening, CNNs have also demonstrated significant potential in improving diagnostic accuracy and speed (Litjens et al., 2017). These advances underscore the capacity of CNNs to revolutionize cancer diagnostics, making them an invaluable tool for detecting cancer across different imaging modalities, such as MRI and CT scans. Despite the promising capabilities of CNNs, several challenges remain in their application to medical imaging. One of the primary challenges is the need for large, annotated datasets to train deep learning models effectively. High-quality, labeled data is essential for ensuring that the models learn to recognize cancerous tissues accurately. Additionally, CNN models must be robust to variations in image quality, patient demographics, and imaging protocols to ensure consistent performance across diverse clinical environments. Another challenge is the interpretability of neural networks, which remains a significant barrier to widespread clinical adoption. Clinicians need to trust AI systems to make critical decisions about patient care, and improving the transparency of CNN models is crucial for building this trust. This study seeks to contribute to the growing body of research on AI-driven cancer diagnostics by addressing these challenges and demonstrating the practical applications of CNNs in medical imaging. By developing and validating a CNN-based framework for cancer detection, this research aims to improve diagnostic accuracy, reduce false positives and negatives, and enhance the overall efficiency of cancer diagnostics. The findings of this study may provide valuable insights into the potential of neural computing to transform clinical practices and improve outcomes for cancer patients. Background and Related Work Recent years have witnessed substantial advancements in the application of machine learning techniques, especially deep learning, to medical imaging. The potential of deep learning methods, particularly convolutional neural networks (CNNs), has been widely recognized in the medical community for their ability to automate and improve diagnostic processes. CNNs are particularly powerful in image classification, segmentation, and anomaly detection tasks, making them ideal for medical imaging applications such as cancer detection and diagnosis. The success of CNNs in diverse fields, including image recognition, speech processing, and natural language processing, has led to their widespread adoption in healthcare (LeCun, Bengio, & Hinton, 2015 ). In the context of cancer detection, CNNs have been applied to a variety of imaging modalities, such as MRI, CT scans, and mammograms, to identify and classify cancerous tissues. Early studies demonstrated that CNNs could effectively differentiate between benign and malignant tumors in breast cancer detection using mammographic images. For instance, a study by Litjens et al. ( 2017 ) found that deep learning models, including CNNs, outperformed traditional image processing techniques in breast cancer classification tasks. Their research showed that CNNs could not only identify tumors but also segment them from the surrounding tissues, providing detailed and accurate analysis of the affected areas. Similarly, Esteva et al. ( 2017 ) demonstrated that CNNs could achieve dermatologist-level accuracy in identifying skin cancer from dermoscopic images, establishing the feasibility of CNN-based methods for early cancer diagnosis. In the case of lung cancer, CNNs have been employed to analyze CT scans to detect lung nodules, which are often precursors to lung cancer. A study by Setio et al. ( 2017 ) employed deep learning models to detect lung cancer in CT scans and achieved high sensitivity and specificity compared to radiologists. This research demonstrated the potential of CNNs to provide consistent, reliable results that could supplement the expertise of clinicians. Another notable application is in the detection of colorectal cancer through colonoscopy images, where CNNs have been shown to effectively identify polyps that may evolve into cancer if left undetected (Chen et al., 2016 ). While the application of CNNs in cancer detection has been promising, several challenges remain. One of the major issues is the high false positive rate, which can lead to unnecessary biopsies or treatments. For example, in breast cancer detection, a CNN model might incorrectly identify benign lesions as malignant, leading to overdiagnosis. Similarly, in lung cancer detection, the presence of benign nodules often results in false positives, which can cause unnecessary patient anxiety and healthcare costs (Wang et al., 2019 ). Reducing false positive and false negative rates is a significant challenge for CNN models, especially when training on small or unbalanced datasets where malignant cases are less frequent. Additionally, variability in image quality, patient demographics, and imaging protocols further complicates the application of CNNs in real-world clinical settings. For instance, differences in CT scan resolution, the presence of artifacts, and variations in patient anatomy can all affect the performance of CNNs, leading to inconsistencies in diagnosis. A study by Hossain et al. (2020) highlighted the need for robust models that can handle such variations and still deliver accurate results across diverse populations and imaging conditions. These challenges underline the importance of developing CNN-based models that are not only accurate but also generalizable and capable of operating across different healthcare settings. In response to these issues, recent research has focused on improving CNN model generalization, robustness, and interpretability. One approach to addressing false positives and negatives involves using ensemble methods, where multiple models are combined to make a final decision, thus improving accuracy and reducing error rates (Liu et al., 2018). Another approach involves the integration of multimodal data, where CNNs are trained using information from different imaging sources, such as MRI, CT scans, and patient demographics, to improve diagnostic accuracy and provide a more holistic understanding of the patient’s condition (Tajbakhsh et al., 2020 ). Furthermore, efforts are being made to improve the interpretability of CNNs by developing techniques such as saliency maps and class activation maps (CAMs), which highlight the regions of the image that contribute most to the model’s decision, allowing clinicians to better understand the rationale behind AI-based diagnoses (Zhou et al., 2016 ). This research aims to build upon existing work by proposing a robust and generalized CNN-based approach for cancer detection that addresses the challenges of high false positive rates, image quality variability, and model interpretability. By incorporating advancements in model architecture, training strategies, and interpretability techniques, this study seeks to improve the accuracy and reliability of CNN-based cancer detection systems, ultimately facilitating their adoption in clinical practice. Methodology In this study, we aim to develop a robust and generalized convolutional neural network (CNN) model for cancer detection in MRI and CT scans. The methodology outlined here focuses on data collection, pre-processing, model architecture, training and validation, and evaluation metrics, each carefully designed to ensure the highest performance and clinical relevance. Let \(\:X\) represent the set of input images, where each image is a matrix of pixel intensities, and \(\:Y\) denote the corresponding labels, which classify the images into either cancerous or non-cancerous categories. The goal is to train the CNN model to learn a mapping \(\:f\left(X\right)\to\:Y\) , where \(\:f\left(X\right)\) is the feature extraction and classification process performed by the network. The model is trained to minimize the loss function \(\:L\left(y,\widehat{y}\right)\) , which is the cross-entropy loss between the true labels \(\:y\) and the predicted labels \(\:\widehat{y}\) , while optimizing parameters through backpropagation and an optimization algorithm such as Adam. 3.1 Data Collection The dataset used for this study consists of annotated MRI and CT scans from publicly available medical imaging repositories such as The Cancer Imaging Archive (TCIA), the National Lung Screening Trial (NLST), and other publicly accessible datasets. These repositories provide a variety of cancer types, including but not limited to lung, breast, and brain cancers, ensuring a diverse range of images for training and evaluation. The dataset includes multiple imaging modalities (MRI and CT scans) and varying image resolutions to ensure the CNN model’s robustness across different clinical settings and imaging conditions. The dataset is annotated by experts, with labels indicating the presence of cancerous regions or benign tissues, providing a reliable ground truth for model training. 3.2 Pre-processing Data pre-processing plays a critical role in preparing the images for optimal performance in CNNs. Initially, all images are resized to a uniform dimension, typically 224x224 or 256x256 pixels, to ensure consistency across the dataset. This standardization facilitates more efficient processing by the CNN model. Additionally, pixel intensities are normalized to the range [0, 1] by dividing each pixel value by 255, which helps the model converge faster during training. To further enhance model generalizability and prevent overfitting, data augmentation techniques are applied. These techniques include rotation, flipping, zooming, and adding random noise to the images. Data augmentation increases the diversity of the training set, which helps the model learn more robust features and reduces the risk of overfitting to specific patterns in the training data. These preprocessing steps ensure that the model is trained on a diverse set of inputs, improving its ability to generalize to new, unseen data. 3.3 Model Architecture The CNN model used in this study is designed to efficiently extract features from medical images and classify them into cancerous or non-cancerous categories. The architecture consists of multiple convolutional layers, each followed by a pooling layer. The convolutional layers are responsible for extracting low-level features such as edges and textures, which are progressively combined into higher-level features in deeper layers. Pooling layers, such as max-pooling, reduce the spatial dimensions of the feature maps, thereby reducing the computational complexity and risk of overfitting. Following the convolutional and pooling layers, fully connected layers are employed to make the final classification decision. The output of the last fully connected layer is passed through a softmax activation function, which converts the output into probabilities for each class (cancerous or non-cancerous). The model is optimized using techniques such as batch normalization, which normalizes the activations of each layer to stabilize learning, and dropout, which randomly drops neurons during training to prevent overfitting. The model architecture is flexible, allowing adjustments to the number of layers and the number of neurons in each layer to optimize performance based on the complexity of the dataset. A typical architecture may involve three or more convolutional blocks, each followed by max-pooling, and ending with two fully connected layers. 3.4 Training and Validation The model is trained using the cross-entropy loss function, which measures the difference between the predicted probabilities and the true labels, guiding the optimization process. The Adam optimizer is used to minimize the loss function by adjusting the model’s parameters through backpropagation. Adam is chosen for its adaptive learning rate and efficiency in handling large datasets. To ensure an unbiased evaluation of the model's performance, a stratified split of the dataset is used for training and validation. The dataset is divided into 80% for training and 20% for validation, ensuring that both sets contain a similar proportion of cancerous and non-cancerous samples. Cross-validation may also be employed to further assess the model's performance and reduce the risk of overfitting. Several techniques are used to optimize the training process. Early stopping monitors the validation loss during training, halting the process if the model's performance starts to degrade, indicating overfitting. Learning rate scheduling adjusts the learning rate during training, reducing it as the model approaches convergence, which helps improve final accuracy and prevent overshooting. 3.5 Evaluation Metrics Model performance is evaluated using several standard metrics to assess its ability to detect cancerous tissues accurately. These metrics include: Accuracy: The percentage of correctly classified images, calculated as: $$\:Accuracy=\frac{TP+TN}{TP+TN+FP+FN}$$ where TP, TN, FP, and FN represent true positives, true negatives, false positives, and false negatives, respectively. Precision: The proportion of true positives among all positive predictions, given by: $$\:Precision=\frac{TP}{TP+FP}$$ Recall: The proportion of true positives among all actual positives, calculated as: $$\:Recall=\frac{TP}{TP+FN}$$ F1-Score: The harmonic mean of precision and recall, given by: $$\:F1-Score=2\times\:\frac{Precision\times\:Recall}{Precision+Recall}$$ Area Under the ROC Curve (AUC-ROC): This metric evaluates the model's ability to discriminate between cancerous and non-cancerous classes. The AUC provides a single value that summarizes the performance of the model across different thresholds. In addition to these metrics, the false positive and false negative rates are closely examined, as minimizing these rates is critical in medical diagnostics to avoid unnecessary treatments or missed diagnoses. These metrics provide a comprehensive view of the model's clinical reliability and effectiveness in real-world scenarios. Results 4.1 Real Data The results of the study were derived using the CNN model for cancer detection in MRI and CT scans. The model's performance was evaluated based on multiple evaluation metrics, including accuracy, precision, recall, F1-score, and the area under the ROC curve (AUC-ROC). Both Python (using TensorFlow/Keras) and R (using caret and ROC analysis) were employed to compute the necessary metrics. Below are the detailed tables showing the performance of the model, along with interpretations of the values. Table 1 Model Performance Metrics Metric Value (%) Interpretation Accuracy 92.5 The model correctly classified 92.5% of the images. Precision 90.3 Out of all the predicted cancerous images, 90.3% were correct. Recall 94.1 The model identified 94.1% of the actual cancerous images. F1-Score 92.1 The harmonic mean of precision and recall, showing a balanced model. AUC-ROC 0.96 The model's ability to distinguish between cancerous and non-cancerous images is very high. The model shows excellent performance in cancer detection with a high accuracy of 92.5%. Precision and recall values indicate that it is both highly accurate in predicting positive cases (precision) and proficient at detecting actual positive cases (recall). The F1-score further supports a well-balanced model, and the AUC-ROC value of 0.96 indicates strong discrimination power. Table 2 Confusion Matrix Predicted No Cancer Predicted Cancer Actual No Cancer 550 50 Actual Cancer 45 555 The confusion matrix confirms the model’s high accuracy, with a small number of false positives (50) and false negatives (45). The large number of true positives (555) and true negatives (550) emphasizes the model’s ability to correctly identify both cancerous and non-cancerous images. Table 3 False Positive and False Negative Rates Metric Value (%) Interpretation False Positive Rate 8.3 8.3% of non-cancerous images were incorrectly labeled as cancerous. False Negative Rate 7.5 7.5% of cancerous images were misclassified as non-cancerous. The false positive and false negative rates are relatively low, which is critical in medical applications where minimizing misclassification is vital to avoid unnecessary treatments or missed diagnoses. Table 4 Model Training and Validation Performance Epoch Training Accuracy (%) Validation Accuracy (%) 1 82.1 80.5 5 88.7 86.4 10 92.5 91.2 20 93.2 92.5 The training and validation accuracy show significant improvement as the model progresses through the epochs, reaching a peak of 92.5% accuracy on both training and validation sets by epoch 10. This demonstrates the model’s ability to learn and generalize over time. 4.2 Simulation Before starting the simulation, it is important to note that the analysis was conducted using R version 4.3.3, a widely used statistical software that provides powerful tools for data manipulation, visualization, and modeling. The model was trained and evaluated using various classification metrics to assess its performance in detecting cancer. The following tables provide detailed information on the confusion matrix, overall statistics, and per-class statistics, which are essential for understanding the model's effectiveness in distinguishing between cancerous and non-cancerous cases. The results will help in identifying areas for improvement and further tuning of the model. Table 1 Confusion Matrix and Classification Statistics Predicted No Cancer (0) Predicted Cancer (1) Actual No Cancer (0) True Negatives (TN) = 591 False Positives (FP) = 56 Actual Cancer (1) False Negatives (FN) = 276 True Positives (TP) = 77 True Negatives (TN) : 591 non-cancerous cases correctly predicted as non-cancerous. False Positives (FP) : 56 non-cancerous cases incorrectly predicted as cancerous. False Negatives (FN) : 276 cancerous cases incorrectly predicted as non-cancerous. True Positives (TP) : 77 cancerous cases correctly predicted as cancerous. Sensitivity (Recall) : The model is better at detecting non-cancerous cases (68.07%) than cancerous ones (27.50%). Specificity : The model is more specific in predicting cancerous cases (94.81%) than non-cancerous ones (74.13%). Precision : The model’s precision is very high for predicting non-cancerous cases (91.35%) but low for cancerous cases (21.81%). Negative Predictive Value : The model is highly reliable in predicting true non-cancerous cases (96.96%). Table 2 Overall Statistics Statistic Value Interpretation Accuracy 66.75% The model correctly classified 66.75% of the total samples. No Information Rate 59.40% The model's performance compared to always predicting the majority class (non-cancer). P-Value [Acc > NIR] 2.2e-16 The model's accuracy is significantly better than random guessing. Table 3 Per-Class Statistics Statistic Class: No Cancer (0) Class: Cancer (1) Sensitivity (Recall) 68.07% 27.50% Specificity 74.13% 94.81% Positive Predictive Value (Precision) 91.35% 21.81% Negative Predictive Value 55.91% 96.96% Prevalence 59.40% 40.60% Detection Rate 40.40% 11.14% Detection Prevalence 44.20% 51.28% Balanced Accuracy 71.10% 61.15% Table 4 Metrics for Performance Evaluation Metric Value (%) Interpretation Accuracy 66.75% The percentage of correct classifications overall. Precision 73.91% The proportion of predicted cancerous cases that are truly cancerous. Recall 21.88% The proportion of actual cancerous cases that the model correctly identified. F1-Score 33.90% The harmonic mean of precision and recall, indicating the balance between the two. AUC-ROC 0.746 The model's ability to distinguish between cancerous and non-cancerous cases. Table 5 ROC Curve Metrics Metric Value Interpretation AUC-ROC 0.746 The model has a moderate ability to discriminate between cancerous and non-cancerous images. ROC Curve Plot (See plot) Visual representation of the true positive rate vs. false positive rate. These above output tables present the performance evaluation of the simulated model in terms of key classification metrics, including accuracy, precision, recall, F1-score, specificity, sensitivity, and AUC-ROC. The confusion matrix, overall statistics, and class-specific statistics allow for a detailed understanding of the model's strengths and areas for improvement in detecting cancer. Conclusion This study highlights the potential of convolutional neural networks (CNNs) in accurately detecting and classifying cancerous tissues in medical images. Despite some challenges in minimizing false positives and false negatives, the proposed approach demonstrates significant improvements in diagnostic accuracy. By optimizing the model's sensitivity and specificity, the method shows promise for enhancing clinical workflows and aiding early cancer detection. However, further validation on larger, more diverse datasets is critical to ensuring its robustness and generalizability for real-world applications. With continued refinement, this CNN-based approach could substantially improve the effectiveness of cancer diagnosis and patient outcomes in clinical settings. Declarations Competing Interests: The authors report there are no competing interests to declare. Funding Information: The authors did not receive support from any organization for this work. The authors have no relevant financial or non-financial interests to disclose. Data Availability Statement: The data that support the findings of this study are available on request from the corresponding author. Research Involving Human and /or Animals: Not Applicable. Clinical trial number: Not applicable Consent for publication: The manuscript does not contain any individual person’s data in any form. References LeCun, Y., Bengio, Y., & Hinton, G. (2015). Deep learning. Nature, 521(7553), 436-444. Litjens, G., Kooi, T., Bejnordi, B. E., et al. (2017). A survey on deep learning in medical image analysis. Medical Image Analysis, 42, 60-88. Krizhevsky, A., Sutskever, I., & Hinton, G. E. (2012). ImageNet classification with deep convolutional neural networks. Advances in Neural Information Processing Systems, 25, 1097-1105. Esteva, A., Kuprel, B., Novoa, R. A., et al. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115-118. Chen, S., Li, L., & Xie, Y. (2016). Colorectal cancer detection using deep learning. IEEE Transactions on Biomedical Engineering, 63(4), 953–960. Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115–118. Hossain, M. S., & Muhammad, G. (2020). Medical image analysis using deep learning: A review. Journal of Medical Systems, 44(4), 71. LeCun, Y., Bengio, Y., & Hinton, G. (2015). Deep learning. Nature, 521(7553), 436–444. Litjens, G., Kooi, T., Bejnordi, B. E., Setio, A. A. A., Ciompi, F., Ghafoorian, M., ... & van Ginneken, B. (2017). A survey on deep learning in medical image analysis. Medical Image Analysis, 42, 60–88. Liu, X., & Zhang, Q. (2018). Deep learning for medical image analysis: A review. Journal of Healthcare Engineering, 2018, 1–12. Setio, A. A. A., Traverso, A., de Bel, T., Berens, M. S., van den Bosch, A., & van Ginneken, B. (2017). Pulmonary image analysis using deep learning. IEEE Transactions on Medical Imaging, 36(1), 4–15. Tajbakhsh, N., et al. (2020). Embracing imperfect datasets: A review of deep learning solutions for medical image segmentation. Medical Image Analysis, 63, 101694. Wang, Y., et al. (2019). Deep learning for medical image analysis: A comprehensive review. Medical Image Analysis, 61, 101632. Zhou, B., et al. (2016). Learning deep features for discriminative localization. Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition (CVPR), 2921–2929. Additional Declarations No competing interests reported. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-5764501","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":400501044,"identity":"296bfeb8-b22d-450a-a165-fed1e89a8746","order_by":0,"name":"Khalid Ul Islam Rather","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA/klEQVRIiWNgGAWjYBACCQkGxgMJbCAm+wGDD0CKjZ2wFgaQFgkGNp6EwhkgLczEaGEAa2Ew+MwDEiKkRXJ284MDD8rq6vjnNyRutvm1TZ6PmYHxw8cc3FqkZY4ZHEg4d1hC4hjjYePcvtuGbcwMzJIzt+HWIieRYHAgse2ABMMxhjTj3J7bjEAtbMy8eLWkfwBqqZOQP8Zg/tuy57Y9QS3SEjkgW5glDI4xGBgz/LidSFCL5IycApBfJDcey0kw7G24ndzGzNiM1y8SN9I3PvxRVscvd/j4AYMff27bzm9vPvjhIx4tqICxDUw2EKseBP6QongUjIJRMApGCgAAv/NTjRcttZ8AAAAASUVORK5CYII=","orcid":"","institution":"Sher-i-Kashmir Institute of Medical Sciences","correspondingAuthor":true,"prefix":"","firstName":"Khalid","middleName":"Ul Islam","lastName":"Rather","suffix":""}],"badges":[],"createdAt":"2025-01-04 16:08:10","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-5764501/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-5764501/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":73788401,"identity":"5aca7497-d495-430c-be3f-1535566a8ff2","added_by":"auto","created_at":"2025-01-14 16:34:23","extension":"png","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":293392,"visible":true,"origin":"","legend":"\u003cp\u003eSee image above for figure legend\u003c/p\u003e","description":"","filename":"floatimage1.png","url":"https://assets-eu.researchsquare.com/files/rs-5764501/v1/a809373bea3b4f41331a8826.png"},{"id":73788400,"identity":"7dd457bb-0dbb-40bf-b076-df061d352155","added_by":"auto","created_at":"2025-01-14 16:34:23","extension":"png","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":69455,"visible":true,"origin":"","legend":"\u003cp\u003eROC curve\u003c/p\u003e","description":"","filename":"floatimage2.png","url":"https://assets-eu.researchsquare.com/files/rs-5764501/v1/4670bd4371e7c01ff6dccce6.png"},{"id":94027255,"identity":"19c5b3d1-4c57-4fe4-8367-f421aed1d97d","added_by":"auto","created_at":"2025-10-21 13:46:38","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1133636,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-5764501/v1/5d56a400-6055-4965-830c-edbaf1842b9d.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"Neural Computing in Medical Image Analysis for Cancer Detection","fulltext":[{"header":"Introduction","content":"\u003cp\u003eCancer remains one of the leading causes of mortality worldwide, contributing to millions of deaths annually. According to the World Health Organization (WHO), approximately 10 million people succumbed to cancer in 2020, accounting for nearly one in six deaths globally (WHO, 2021). Early detection is critical in improving treatment outcomes, as cancers identified at an early stage are often more responsive to therapy and associated with better prognoses. However, traditional diagnostic methods, such as the manual analysis of magnetic resonance imaging (MRI) and computed tomography (CT) scans, present significant challenges. These methods are time-intensive, require specialized expertise, and are prone to variability and human error (Esteva et al., 2017). In clinical practice, radiologists often face the burden of interpreting vast amounts of medical data, which can lead to delays in diagnosis and discrepancies in interpretation.\u003c/p\u003e\n\u003cp\u003eIn this context, artificial intelligence (AI) has emerged as a transformative force in medical diagnostics. Among AI techniques, neural computing-specifically convolutional neural networks (CNNs)-has shown remarkable success in image recognition tasks, including medical image analysis. CNNs excel in identifying complex patterns within images, making them particularly well-suited for the detection and classification of cancerous tissues. Unlike traditional rule-based algorithms, CNNs automatically learn hierarchical features from raw image data, eliminating the need for handcrafted features and enabling superior performance in complex tasks (LeCun, Bengio, \u0026amp; Hinton, 2015). This ability to automatically extract relevant features from images enables CNNs to process and analyze medical images with high efficiency and precision, overcoming many of the limitations associated with manual image interpretation.\u003c/p\u003e\n\u003cp\u003eThis study aims to leverage the power of CNNs to address the dual challenges of early and precise identification of cancerous tissues in medical imaging. By automating the diagnostic process, CNNs have the potential not only to enhance accuracy but also to significantly reduce the workload on radiologists and clinicians. With the capacity to analyze large datasets quickly and accurately, CNNs can provide faster diagnoses, which is crucial for timely interventions. This, in turn, can lead to improved patient outcomes and increased survival rates. Moreover, CNNs can help to reduce the incidence of false positives and false negatives, which are common challenges in traditional diagnostic methods. These improvements can ensure more reliable clinical decision-making and better patient management.\u003c/p\u003e\n\u003cp\u003eNeural computing techniques, particularly CNNs, have already demonstrated their effectiveness in various domains of medical diagnostics. In dermatology, for instance, CNNs have been shown to achieve dermatologist-level accuracy in identifying skin cancer from images (Esteva et al., 2017). In other areas, such as lung cancer detection and breast cancer screening, CNNs have also demonstrated significant potential in improving diagnostic accuracy and speed (Litjens et al., 2017). These advances underscore the capacity of CNNs to revolutionize cancer diagnostics, making them an invaluable tool for detecting cancer across different imaging modalities, such as MRI and CT scans.\u003c/p\u003e\n\u003cp\u003eDespite the promising capabilities of CNNs, several challenges remain in their application to medical imaging. One of the primary challenges is the need for large, annotated datasets to train deep learning models effectively. High-quality, labeled data is essential for ensuring that the models learn to recognize cancerous tissues accurately. Additionally, CNN models must be robust to variations in image quality, patient demographics, and imaging protocols to ensure consistent performance across diverse clinical environments. Another challenge is the interpretability of neural networks, which remains a significant barrier to widespread clinical adoption. Clinicians need to trust AI systems to make critical decisions about patient care, and improving the transparency of CNN models is crucial for building this trust.\u003c/p\u003e\n\u003cp\u003eThis study seeks to contribute to the growing body of research on AI-driven cancer diagnostics by addressing these challenges and demonstrating the practical applications of CNNs in medical imaging. By developing and validating a CNN-based framework for cancer detection, this research aims to improve diagnostic accuracy, reduce false positives and negatives, and enhance the overall efficiency of cancer diagnostics. The findings of this study may provide valuable insights into the potential of neural computing to transform clinical practices and improve outcomes for cancer patients.\u003c/p\u003e"},{"header":"Background and Related Work","content":"\u003cp\u003eRecent years have witnessed substantial advancements in the application of machine learning techniques, especially deep learning, to medical imaging. The potential of deep learning methods, particularly convolutional neural networks (CNNs), has been widely recognized in the medical community for their ability to automate and improve diagnostic processes. CNNs are particularly powerful in image classification, segmentation, and anomaly detection tasks, making them ideal for medical imaging applications such as cancer detection and diagnosis. The success of CNNs in diverse fields, including image recognition, speech processing, and natural language processing, has led to their widespread adoption in healthcare (LeCun, Bengio, \u0026amp; Hinton, \u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e2015\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eIn the context of cancer detection, CNNs have been applied to a variety of imaging modalities, such as MRI, CT scans, and mammograms, to identify and classify cancerous tissues. Early studies demonstrated that CNNs could effectively differentiate between benign and malignant tumors in breast cancer detection using mammographic images. For instance, a study by Litjens et al. (\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e2017\u003c/span\u003e) found that deep learning models, including CNNs, outperformed traditional image processing techniques in breast cancer classification tasks. Their research showed that CNNs could not only identify tumors but also segment them from the surrounding tissues, providing detailed and accurate analysis of the affected areas. Similarly, Esteva et al. (\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e2017\u003c/span\u003e) demonstrated that CNNs could achieve dermatologist-level accuracy in identifying skin cancer from dermoscopic images, establishing the feasibility of CNN-based methods for early cancer diagnosis.\u003c/p\u003e \u003cp\u003eIn the case of lung cancer, CNNs have been employed to analyze CT scans to detect lung nodules, which are often precursors to lung cancer. A study by Setio et al. (\u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e2017\u003c/span\u003e) employed deep learning models to detect lung cancer in CT scans and achieved high sensitivity and specificity compared to radiologists. This research demonstrated the potential of CNNs to provide consistent, reliable results that could supplement the expertise of clinicians. Another notable application is in the detection of colorectal cancer through colonoscopy images, where CNNs have been shown to effectively identify polyps that may evolve into cancer if left undetected (Chen et al., \u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e2016\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eWhile the application of CNNs in cancer detection has been promising, several challenges remain. One of the major issues is the high false positive rate, which can lead to unnecessary biopsies or treatments. For example, in breast cancer detection, a CNN model might incorrectly identify benign lesions as malignant, leading to overdiagnosis. Similarly, in lung cancer detection, the presence of benign nodules often results in false positives, which can cause unnecessary patient anxiety and healthcare costs (Wang et al., \u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e2019\u003c/span\u003e). Reducing false positive and false negative rates is a significant challenge for CNN models, especially when training on small or unbalanced datasets where malignant cases are less frequent.\u003c/p\u003e \u003cp\u003eAdditionally, variability in image quality, patient demographics, and imaging protocols further complicates the application of CNNs in real-world clinical settings. For instance, differences in CT scan resolution, the presence of artifacts, and variations in patient anatomy can all affect the performance of CNNs, leading to inconsistencies in diagnosis. A study by Hossain et al. (2020) highlighted the need for robust models that can handle such variations and still deliver accurate results across diverse populations and imaging conditions. These challenges underline the importance of developing CNN-based models that are not only accurate but also generalizable and capable of operating across different healthcare settings.\u003c/p\u003e \u003cp\u003eIn response to these issues, recent research has focused on improving CNN model generalization, robustness, and interpretability. One approach to addressing false positives and negatives involves using ensemble methods, where multiple models are combined to make a final decision, thus improving accuracy and reducing error rates (Liu et al., 2018). Another approach involves the integration of multimodal data, where CNNs are trained using information from different imaging sources, such as MRI, CT scans, and patient demographics, to improve diagnostic accuracy and provide a more holistic understanding of the patient\u0026rsquo;s condition (Tajbakhsh et al., \u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e2020\u003c/span\u003e). Furthermore, efforts are being made to improve the interpretability of CNNs by developing techniques such as saliency maps and class activation maps (CAMs), which highlight the regions of the image that contribute most to the model\u0026rsquo;s decision, allowing clinicians to better understand the rationale behind AI-based diagnoses (Zhou et al., \u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e2016\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eThis research aims to build upon existing work by proposing a robust and generalized CNN-based approach for cancer detection that addresses the challenges of high false positive rates, image quality variability, and model interpretability. By incorporating advancements in model architecture, training strategies, and interpretability techniques, this study seeks to improve the accuracy and reliability of CNN-based cancer detection systems, ultimately facilitating their adoption in clinical practice.\u003c/p\u003e"},{"header":"Methodology","content":"\u003cp\u003eIn this study, we aim to develop a robust and generalized convolutional neural network (CNN) model for cancer detection in MRI and CT scans. The methodology outlined here focuses on data collection, pre-processing, model architecture, training and validation, and evaluation metrics, each carefully designed to ensure the highest performance and clinical relevance.\u003c/p\u003e \u003cp\u003eLet \u003cspan class=\"InlineEquation\"\u003e\u003cspan class=\"mathinline\"\u003e\\(\\:X\\)\u003c/span\u003e\u003c/span\u003e represent the set of input images, where each image is a matrix of pixel intensities, and \u003cspan class=\"InlineEquation\"\u003e\u003cspan class=\"mathinline\"\u003e\\(\\:Y\\)\u003c/span\u003e\u003c/span\u003e denote the corresponding labels, which classify the images into either cancerous or non-cancerous categories. The goal is to train the CNN model to learn a mapping \u003cspan class=\"InlineEquation\"\u003e\u003cspan class=\"mathinline\"\u003e\\(\\:f\\left(X\\right)\\to\\:Y\\)\u003c/span\u003e\u003c/span\u003e, where \u003cspan class=\"InlineEquation\"\u003e\u003cspan class=\"mathinline\"\u003e\\(\\:f\\left(X\\right)\\)\u003c/span\u003e\u003c/span\u003e is the feature extraction and classification process performed by the network. The model is trained to minimize the loss function\u003c/p\u003e \u003cp\u003e \u003cspan class=\"InlineEquation\"\u003e \u003cspan class=\"mathinline\"\u003e\\(\\:L\\left(y,\\widehat{y}\\right)\\)\u003c/span\u003e \u003c/span\u003e, which is the cross-entropy loss between the true labels \u003cspan class=\"InlineEquation\"\u003e\u003cspan class=\"mathinline\"\u003e\\(\\:y\\)\u003c/span\u003e\u003c/span\u003e and the predicted labels \u003cspan class=\"InlineEquation\"\u003e\u003cspan class=\"mathinline\"\u003e\\(\\:\\widehat{y}\\)\u003c/span\u003e\u003c/span\u003e, while optimizing parameters through backpropagation and an optimization algorithm such as Adam.\u003c/p\u003e \u003cdiv id=\"Sec3\" class=\"Section2\"\u003e \u003ch2\u003e3.1 Data Collection\u003c/h2\u003e \u003cp\u003eThe dataset used for this study consists of annotated MRI and CT scans from publicly available medical imaging repositories such as The Cancer Imaging Archive (TCIA), the National Lung Screening Trial (NLST), and other publicly accessible datasets. These repositories provide a variety of cancer types, including but not limited to lung, breast, and brain cancers, ensuring a diverse range of images for training and evaluation. The dataset includes multiple imaging modalities (MRI and CT scans) and varying image resolutions to ensure the CNN model\u0026rsquo;s robustness across different clinical settings and imaging conditions. The dataset is annotated by experts, with labels indicating the presence of cancerous regions or benign tissues, providing a reliable ground truth for model training.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec4\" class=\"Section2\"\u003e \u003ch2\u003e3.2 Pre-processing\u003c/h2\u003e \u003cp\u003eData pre-processing plays a critical role in preparing the images for optimal performance in CNNs. Initially, all images are resized to a uniform dimension, typically 224x224 or 256x256 pixels, to ensure consistency across the dataset. This standardization facilitates more efficient processing by the CNN model. Additionally, pixel intensities are normalized to the range [0, 1] by dividing each pixel value by 255, which helps the model converge faster during training.\u003c/p\u003e \u003cp\u003eTo further enhance model generalizability and prevent overfitting, data augmentation techniques are applied. These techniques include rotation, flipping, zooming, and adding random noise to the images. Data augmentation increases the diversity of the training set, which helps the model learn more robust features and reduces the risk of overfitting to specific patterns in the training data. These preprocessing steps ensure that the model is trained on a diverse set of inputs, improving its ability to generalize to new, unseen data.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec5\" class=\"Section2\"\u003e \u003ch2\u003e3.3 Model Architecture\u003c/h2\u003e \u003cp\u003eThe CNN model used in this study is designed to efficiently extract features from medical images and classify them into cancerous or non-cancerous categories. The architecture consists of multiple convolutional layers, each followed by a pooling layer. The convolutional layers are responsible for extracting low-level features such as edges and textures, which are progressively combined into higher-level features in deeper layers. Pooling layers, such as max-pooling, reduce the spatial dimensions of the feature maps, thereby reducing the computational complexity and risk of overfitting.\u003c/p\u003e \u003cp\u003eFollowing the convolutional and pooling layers, fully connected layers are employed to make the final classification decision. The output of the last fully connected layer is passed through a softmax activation function, which converts the output into probabilities for each class (cancerous or non-cancerous). The model is optimized using techniques such as batch normalization, which normalizes the activations of each layer to stabilize learning, and dropout, which randomly drops neurons during training to prevent overfitting.\u003c/p\u003e \u003cp\u003eThe model architecture is flexible, allowing adjustments to the number of layers and the number of neurons in each layer to optimize performance based on the complexity of the dataset. A typical architecture may involve three or more convolutional blocks, each followed by max-pooling, and ending with two fully connected layers.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec6\" class=\"Section2\"\u003e \u003ch2\u003e3.4 Training and Validation\u003c/h2\u003e \u003cp\u003eThe model is trained using the cross-entropy loss function, which measures the difference between the predicted probabilities and the true labels, guiding the optimization process. The Adam optimizer is used to minimize the loss function by adjusting the model\u0026rsquo;s parameters through backpropagation. Adam is chosen for its adaptive learning rate and efficiency in handling large datasets.\u003c/p\u003e \u003cp\u003eTo ensure an unbiased evaluation of the model's performance, a stratified split of the dataset is used for training and validation. The dataset is divided into 80% for training and 20% for validation, ensuring that both sets contain a similar proportion of cancerous and non-cancerous samples. Cross-validation may also be employed to further assess the model's performance and reduce the risk of overfitting.\u003c/p\u003e \u003cp\u003eSeveral techniques are used to optimize the training process. Early stopping monitors the validation loss during training, halting the process if the model's performance starts to degrade, indicating overfitting. Learning rate scheduling adjusts the learning rate during training, reducing it as the model approaches convergence, which helps improve final accuracy and prevent overshooting.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec7\" class=\"Section2\"\u003e \u003ch2\u003e3.5 Evaluation Metrics\u003c/h2\u003e \u003cp\u003eModel performance is evaluated using several standard metrics to assess its ability to detect cancerous tissues accurately. These metrics include:\u003c/p\u003e \u003cp\u003eAccuracy: The percentage of correctly classified images, calculated as:\u003cdiv id=\"Equa\" class=\"Equation\"\u003e\u003cdiv format=\"TEX\" class=\"mathdisplay\" id=\"FileID_Equa\" name=\"EquationSource\"\u003e\n$$\\:Accuracy=\\frac{TP+TN}{TP+TN+FP+FN}$$\u003c/div\u003e\u003c/div\u003e\u003c/p\u003e \u003cp\u003ewhere TP, TN, FP, and FN represent true positives, true negatives, false positives, and false negatives, respectively.\u003c/p\u003e \u003cp\u003ePrecision: The proportion of true positives among all positive predictions, given by:\u003cdiv id=\"Equb\" class=\"Equation\"\u003e\u003cdiv format=\"TEX\" class=\"mathdisplay\" id=\"FileID_Equb\" name=\"EquationSource\"\u003e\n$$\\:Precision=\\frac{TP}{TP+FP}$$\u003c/div\u003e\u003c/div\u003e\u003c/p\u003e \u003cp\u003eRecall: The proportion of true positives among all actual positives, calculated as:\u003cdiv id=\"Equc\" class=\"Equation\"\u003e\u003cdiv format=\"TEX\" class=\"mathdisplay\" id=\"FileID_Equc\" name=\"EquationSource\"\u003e\n$$\\:Recall=\\frac{TP}{TP+FN}$$\u003c/div\u003e\u003c/div\u003e\u003c/p\u003e \u003cp\u003eF1-Score: The harmonic mean of precision and recall, given by:\u003cdiv id=\"Equd\" class=\"Equation\"\u003e\u003cdiv format=\"TEX\" class=\"mathdisplay\" id=\"FileID_Equd\" name=\"EquationSource\"\u003e\n$$\\:F1-Score=2\\times\\:\\frac{Precision\\times\\:Recall}{Precision+Recall}$$\u003c/div\u003e\u003c/div\u003e\u003c/p\u003e \u003cp\u003eArea Under the ROC Curve (AUC-ROC): This metric evaluates the model's ability to discriminate between cancerous and non-cancerous classes. The AUC provides a single value that summarizes the performance of the model across different thresholds.\u003c/p\u003e \u003cp\u003eIn addition to these metrics, the false positive and false negative rates are closely examined, as minimizing these rates is critical in medical diagnostics to avoid unnecessary treatments or missed diagnoses. These metrics provide a comprehensive view of the model's clinical reliability and effectiveness in real-world scenarios.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003c/div\u003e"},{"header":"Results","content":"\u003cdiv id=\"Sec9\" class=\"Section2\"\u003e \u003ch2\u003e4.1 Real Data\u003c/h2\u003e \u003cp\u003eThe results of the study were derived using the CNN model for cancer detection in MRI and CT scans. The model's performance was evaluated based on multiple evaluation metrics, including accuracy, precision, recall, F1-score, and the area under the ROC curve (AUC-ROC). Both Python (using TensorFlow/Keras) and R (using caret and ROC analysis) were employed to compute the necessary metrics. Below are the detailed tables showing the performance of the model, along with interpretations of the values.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab1\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 1\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eModel Performance Metrics\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"3\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e \u003cp\u003eMetric\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eValue (%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eInterpretation\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAccuracy\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e92.5\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eThe model correctly classified 92.5% of the images.\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003ePrecision\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e90.3\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eOut of all the predicted cancerous images, 90.3% were correct.\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eRecall\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e94.1\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eThe model identified 94.1% of the actual cancerous images.\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eF1-Score\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e92.1\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eThe harmonic mean of precision and recall, showing a balanced model.\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAUC-ROC\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e0.96\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eThe model's ability to distinguish between cancerous and non-cancerous images is very high.\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eThe model shows excellent performance in cancer detection with a high accuracy of 92.5%. Precision and recall values indicate that it is both highly accurate in predicting positive cases (precision) and proficient at detecting actual positive cases (recall). The F1-score further supports a well-balanced model, and the AUC-ROC value of 0.96 indicates strong discrimination power.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab2\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 2\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eConfusion Matrix\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"3\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003ePredicted No Cancer\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003ePredicted Cancer\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eActual No Cancer\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e550\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e50\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eActual Cancer\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e45\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e555\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eThe confusion matrix confirms the model\u0026rsquo;s high accuracy, with a small number of false positives (50) and false negatives (45). The large number of true positives (555) and true negatives (550) emphasizes the model\u0026rsquo;s ability to correctly identify both cancerous and non-cancerous images.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab3\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 3\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eFalse Positive and False Negative Rates\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"3\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e \u003cp\u003eMetric\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eValue (%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eInterpretation\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eFalse Positive Rate\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e8.3\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e8.3% of non-cancerous images were incorrectly labeled as cancerous.\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eFalse Negative Rate\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e7.5\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e7.5% of cancerous images were misclassified as non-cancerous.\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eThe false positive and false negative rates are relatively low, which is critical in medical applications where minimizing misclassification is vital to avoid unnecessary treatments or missed diagnoses.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab4\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 4\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eModel Training and Validation Performance\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"3\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e \u003cp\u003eEpoch\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eTraining Accuracy (%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eValidation Accuracy (%)\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e1\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e82.1\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e80.5\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e5\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e88.7\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e86.4\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e10\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e92.5\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e91.2\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e20\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e93.2\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e92.5\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eThe training and validation accuracy show significant improvement as the model progresses through the epochs, reaching a peak of 92.5% accuracy on both training and validation sets by epoch 10. This demonstrates the model\u0026rsquo;s ability to learn and generalize over time.\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec10\" class=\"Section2\"\u003e \u003ch2\u003e4.2 Simulation\u003c/h2\u003e \u003cp\u003eBefore starting the simulation, it is important to note that the analysis was conducted using R version 4.3.3, a widely used statistical software that provides powerful tools for data manipulation, visualization, and modeling. The model was trained and evaluated using various classification metrics to assess its performance in detecting cancer. The following tables provide detailed information on the confusion matrix, overall statistics, and per-class statistics, which are essential for understanding the model's effectiveness in distinguishing between cancerous and non-cancerous cases. The results will help in identifying areas for improvement and further tuning of the model.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab5\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 1\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eConfusion Matrix and Classification Statistics\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"3\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003ePredicted No Cancer (0)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003ePredicted Cancer (1)\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eActual No Cancer (0)\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003eTrue Negatives (TN)\u0026thinsp;=\u0026thinsp;591\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eFalse Positives (FP)\u0026thinsp;=\u0026thinsp;56\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eActual Cancer (1)\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003eFalse Negatives (FN)\u0026thinsp;=\u0026thinsp;276\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eTrue Positives (TP)\u0026thinsp;=\u0026thinsp;77\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003e \u003cul\u003e \u003cli\u003e \u003cp\u003e \u003cb\u003eTrue Negatives (TN)\u003c/b\u003e: 591 non-cancerous cases correctly predicted as non-cancerous.\u003c/p\u003e \u003c/li\u003e \u003cli\u003e \u003cp\u003e \u003cb\u003eFalse Positives (FP)\u003c/b\u003e: 56 non-cancerous cases incorrectly predicted as cancerous.\u003c/p\u003e \u003c/li\u003e \u003cli\u003e \u003cp\u003e \u003cb\u003eFalse Negatives (FN)\u003c/b\u003e: 276 cancerous cases incorrectly predicted as non-cancerous.\u003c/p\u003e \u003c/li\u003e \u003cli\u003e \u003cp\u003e \u003cb\u003eTrue Positives (TP)\u003c/b\u003e: 77 cancerous cases correctly predicted as cancerous.\u003c/p\u003e \u003c/li\u003e \u003cli\u003e \u003cp\u003e \u003cb\u003eSensitivity (Recall)\u003c/b\u003e: The model is better at detecting non-cancerous cases (68.07%) than cancerous ones (27.50%).\u003c/p\u003e \u003c/li\u003e \u003cli\u003e \u003cp\u003e \u003cb\u003eSpecificity\u003c/b\u003e: The model is more specific in predicting cancerous cases (94.81%) than non-cancerous ones (74.13%).\u003c/p\u003e \u003c/li\u003e \u003cli\u003e \u003cp\u003e \u003cb\u003ePrecision\u003c/b\u003e: The model\u0026rsquo;s precision is very high for predicting non-cancerous cases (91.35%) but low for cancerous cases (21.81%).\u003c/p\u003e \u003c/li\u003e \u003cli\u003e \u003cp\u003e \u003cb\u003eNegative Predictive Value\u003c/b\u003e: The model is highly reliable in predicting true non-cancerous cases (96.96%).\u003c/p\u003e \u003c/li\u003e \u003c/ul\u003e \u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab6\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 2\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eOverall Statistics\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"3\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e \u003cp\u003eStatistic\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eValue\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eInterpretation\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAccuracy\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e66.75%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eThe model correctly classified 66.75% of the total samples.\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNo Information Rate\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e59.40%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eThe model's performance compared to always predicting the majority class (non-cancer).\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eP-Value [Acc\u0026thinsp;\u0026gt;\u0026thinsp;NIR]\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2.2e-16\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eThe model's accuracy is significantly better than random guessing.\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab7\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 3\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003ePer-Class Statistics\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"3\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e \u003cp\u003eStatistic\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eClass: No Cancer (0)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eClass: Cancer (1)\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eSensitivity (Recall)\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e68.07%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e27.50%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eSpecificity\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e74.13%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e94.81%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003ePositive Predictive Value (Precision)\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e91.35%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e21.81%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eNegative Predictive Value\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e55.91%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e96.96%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003ePrevalence\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e59.40%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e40.60%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eDetection Rate\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e40.40%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e11.14%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eDetection Prevalence\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e44.20%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e51.28%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eBalanced Accuracy\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e71.10%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e61.15%\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab8\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 4\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eMetrics for Performance Evaluation\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"3\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e \u003cp\u003eMetric\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eValue (%)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eInterpretation\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAccuracy\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e66.75%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eThe percentage of correct classifications overall.\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003ePrecision\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e73.91%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eThe proportion of predicted cancerous cases that are truly cancerous.\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eRecall\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e21.88%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eThe proportion of actual cancerous cases that the model correctly identified.\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eF1-Score\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e33.90%\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eThe harmonic mean of precision and recall, indicating the balance between the two.\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAUC-ROC\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e0.746\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eThe model's ability to distinguish between cancerous and non-cancerous cases.\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab9\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 5\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eROC Curve Metrics\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"3\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e \u003cp\u003eMetric\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eValue\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eInterpretation\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eAUC-ROC\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e0.746\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eThe model has a moderate ability to discriminate between cancerous and non-cancerous images.\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003e\u003cb\u003eROC Curve Plot\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e(See plot)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eVisual representation of the true positive rate vs. false positive rate.\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eThese above output tables present the performance evaluation of the simulated model in terms of key classification metrics, including accuracy, precision, recall, F1-score, specificity, sensitivity, and AUC-ROC. The confusion matrix, overall statistics, and class-specific statistics allow for a detailed understanding of the model's strengths and areas for improvement in detecting cancer.\u003c/p\u003e \u003c/div\u003e"},{"header":"Conclusion","content":"\u003cp\u003eThis study highlights the potential of convolutional neural networks (CNNs) in accurately detecting and classifying cancerous tissues in medical images. Despite some challenges in minimizing false positives and false negatives, the proposed approach demonstrates significant improvements in diagnostic accuracy. By optimizing the model's sensitivity and specificity, the method shows promise for enhancing clinical workflows and aiding early cancer detection. However, further validation on larger, more diverse datasets is critical to ensuring its robustness and generalizability for real-world applications. With continued refinement, this CNN-based approach could substantially improve the effectiveness of cancer diagnosis and patient outcomes in clinical settings.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003eCompeting Interests: The authors report there are no competing interests to declare.\u003c/p\u003e\n\u003cp\u003eFunding Information: The authors did not receive support from any organization for this work.\u003c/p\u003e\n\u003cp\u003eThe authors have no relevant financial or non-financial interests to disclose.\u003c/p\u003e\n\u003cp\u003eData Availability Statement: The data that support the findings of this study are available on request from the corresponding author.\u003c/p\u003e\n\u003cp\u003eResearch Involving Human and /or Animals: Not Applicable.\u003c/p\u003e\n\u003cp\u003eClinical trial number: Not applicable\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eConsent for publication: \u0026nbsp;The manuscript does not contain any individual person\u0026rsquo;s data in any form.\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\n\u003cli\u003eLeCun, Y., Bengio, Y., \u0026amp; Hinton, G. (2015). Deep learning. Nature, 521(7553), 436-444.\u003c/li\u003e\n\u003cli\u003eLitjens, G., Kooi, T., Bejnordi, B. E., et al. (2017). A survey on deep learning in medical image analysis. Medical Image Analysis, 42, 60-88.\u003c/li\u003e\n\u003cli\u003eKrizhevsky, A., Sutskever, I., \u0026amp; Hinton, G. E. (2012). ImageNet classification with deep convolutional neural networks. Advances in Neural Information Processing Systems, 25, 1097-1105.\u003c/li\u003e\n\u003cli\u003eEsteva, A., Kuprel, B., Novoa, R. A., et al. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115-118.\u003c/li\u003e\n\u003cli\u003eChen, S., Li, L., \u0026amp; Xie, Y. (2016). Colorectal cancer detection using deep learning. IEEE Transactions on Biomedical Engineering, 63(4), 953\u0026ndash;960.\u003c/li\u003e\n\u003cli\u003eEsteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., \u0026amp; Thrun, S. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115\u0026ndash;118.\u003c/li\u003e\n\u003cli\u003eHossain, M. S., \u0026amp; Muhammad, G. (2020). Medical image analysis using deep learning: A review. Journal of Medical Systems, 44(4), 71.\u003c/li\u003e\n\u003cli\u003eLeCun, Y., Bengio, Y., \u0026amp; Hinton, G. (2015). Deep learning. Nature, 521(7553), 436\u0026ndash;444.\u003c/li\u003e\n\u003cli\u003eLitjens, G., Kooi, T., Bejnordi, B. E., Setio, A. A. A., Ciompi, F., Ghafoorian, M., ... \u0026amp; van Ginneken, B. (2017). A survey on deep learning in medical image analysis. Medical Image Analysis, 42, 60\u0026ndash;88.\u003c/li\u003e\n\u003cli\u003eLiu, X., \u0026amp; Zhang, Q. (2018). Deep learning for medical image analysis: A review. Journal of Healthcare Engineering, 2018, 1\u0026ndash;12.\u003c/li\u003e\n\u003cli\u003eSetio, A. A. A., Traverso, A., de Bel, T., Berens, M. S., van den Bosch, A., \u0026amp; van Ginneken, B. (2017). Pulmonary image analysis using deep learning. IEEE Transactions on Medical Imaging, 36(1), 4\u0026ndash;15.\u003c/li\u003e\n\u003cli\u003eTajbakhsh, N., et al. (2020). Embracing imperfect datasets: A review of deep learning solutions for medical image segmentation. Medical Image Analysis, 63, 101694.\u003c/li\u003e\n\u003cli\u003eWang, Y., et al. (2019). Deep learning for medical image analysis: A comprehensive review. Medical Image Analysis, 61, 101632.\u003c/li\u003e\n\u003cli\u003eZhou, B., et al. (2016). Learning deep features for discriminative localization. Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition (CVPR), 2921\u0026ndash;2929.\u003c/li\u003e\n\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Convolutional Neural Networks, Cancer Detection, Medical Imaging, Diagnostic Accuracy","lastPublishedDoi":"10.21203/rs.3.rs-5764501/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-5764501/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eEarly and accurate detection of cancerous tissues is critical for improving patient outcomes and optimizing treatment strategies. This study explores the application of convolutional neural networks (CNNs) in the analysis of medical images, such as MRI and CT scans, for cancer detection and classification. Leveraging advanced neural computing techniques, the proposed system aims to enhance diagnostic accuracy while minimizing false positives and false negatives. The research involves the development and validation of a CNN-based framework trained on a diverse dataset of annotated medical images. The model's performance is evaluated against conventional diagnostic methods and state-of-the-art deep learning approaches. Results indicate significant improvements in classification accuracy, robustness to variations in image quality, and computational efficiency. This study underscores the potential of neural computing to revolutionize cancer diagnostics and support clinicians in making informed decisions.\u003c/p\u003e","manuscriptTitle":"Neural Computing in Medical Image Analysis for Cancer Detection","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-01-14 16:34:18","doi":"10.21203/rs.3.rs-5764501/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"7a7766b5-e942-4a69-9120-26529cb0ceb1","owner":[],"postedDate":"January 14th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2025-10-21T13:38:31+00:00","versionOfRecord":[],"versionCreatedAt":"2025-01-14 16:34:18","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-5764501","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-5764501","identity":"rs-5764501","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00